Purchases and Sales Made in Q2 2024 in Keros Therapeutics, Inc. (KROS)
This table provides information about the institutional ownership of Keros Therapeutics, Inc. (KROS) during Q2 2024. The information is specifically focused on institutions that hold shares of Keros Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Jul 31, 2024
Q2 2024
|
New York State Common Retirement Fund
|
SELL
|
- |
-4.51K- 26.32% |
$201K - $301K
|
12.6K
$837K
|
|
Aug 14, 2024
Q2 2024
|
Paul Tudor Jones
Tudor Investment Corp Et Al | Stamford, Ct
|
SELL
|
- |
-6.65K- 39.09% |
$296K - $445K
|
10.4K
$687K
|
|
Aug 15, 2024
Q2 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-7.04K- 45.66% |
$314K - $471K
|
8.38K
$556K
|
|
Aug 13, 2024
Q2 2024
|
Profund Advisors LLC
|
SELL
|
- |
-7.85K- 42.09% |
$350K - $525K
|
10.8K
$717K
|
|
Jul 30, 2024
Q2 2024
|
Mirae Asset Global Investments Co., Ltd.
|
SELL
|
- |
-12.1K- 91.81% |
$538K - $807K
|
1.08K
$71.4K
|
|
Aug 12, 2024
Q2 2024
|
Platinum Investment Management LTD
Sydney Australia 2000, C3 |
SELL
|
- |
-14.4K- 41.54% |
$643K - $965K
|
20.3K
$1.35M
|
|
Aug 15, 2024
Q2 2024
|
Blue Owl Capital Holdings LP
New York, NY |
SELL
|
- |
-15K- 8.69% |
$669K - $1M
|
158K
$10.5M
|
|
Aug 14, 2024
Q2 2024
|
Fred Alger Management, LLC
New York, NY |
SELL
|
- |
-16.9K- 25.63% |
$753K - $1.13M
|
49K
$3.25M
|
|
Aug 12, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-24.7K- 44.6% |
$1.1M - $1.65M
|
30.7K
$2.04M
|
|
Aug 14, 2024
Q2 2024
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-26.3K- 43.53% |
$1.17M - $1.76M
|
34.1K
$2.26M
|
|
Aug 14, 2024
Q2 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-30.6K- 2.51% |
$1.36M - $2.05M
|
1.19M
$78.8M
|
|
Aug 14, 2024
Q2 2024
|
Hudson Bay Capital Management LP
Greenwich, CT |
SELL
|
- |
-35.4K- 54.1% |
$1.58M - $2.37M
|
30K
$1.99M
|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-39.8K- 8.84% |
$1.77M - $2.66M
|
410K
$27.2M
|
|
Aug 14, 2024
Q2 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-44.7K- 64.12% |
$1.99M - $2.99M
|
25K
$1.66M
|
|
Aug 14, 2024
Q2 2024
|
Soleus Capital Management, L.P.
Greenwich, CT |
SELL
|
- |
-52K- 19.01% |
$2.32M - $3.48M
|
222K
$14.7M
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-58.6K- 47.21% |
$2.61M - $3.92M
|
65.6K
$4.35M
|
|
Aug 13, 2024
Q2 2024
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-62K- 51.84% |
$2.76M - $4.14M
|
57.6K
$3.82M
|
|
Aug 13, 2024
Q2 2024
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-76.8K- 86.62% |
$3.42M - $5.14M
|
11.9K
$787K
|
|
Aug 12, 2024
Q2 2024
|
Citigroup Inc
|
SELL
|
- |
-105K- 89.29% |
$4.68M - $7.01M
|
12.6K
$834K
|
|
Dec 03, 2024
Q2 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-115K- 67.23% |
$5.13M - $7.7M
|
56.1K
$3.72M
|
|
Aug 13, 2024
Q2 2024
|
Eventide Asset Management, LLC
Boston, MA |
SELL
|
- |
-181K- 26.59% |
$8.06M - $12.1M
|
499K
$33.1M
|
|
Aug 05, 2024
Q2 2024
|
Candriam S.C.A.
|
SELL
|
- |
-210K- 32.23% |
$9.37M - $14.1M
|
442K
$29.3M
|
|
Aug 14, 2024
Q2 2024
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-232K- 36.68% |
$10.3M - $15.5M
|
400K
$26.5M
|
|
Aug 14, 2024
Q2 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-251K- 91.8% |
$11.2M - $16.8M
|
22.4K
$1.48M
|
|
Aug 14, 2024
Q2 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-342K- 21.85% |
$15.2M - $22.8M
|
1.22M
$81M
|
|
Aug 14, 2024
Q2 2024
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-602K- 61.89% |
$26.8M - $40.2M
|
370K
$24.6M
|